These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1092 related articles for article (PubMed ID: 26019136)
1. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4. Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]
3. Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma. Pandit H; Zhang W; Li Y; Agle S; Li X; Li SP; Cui G; Li Y; Martin RC Cancer Gene Ther; 2015 Oct; 22(10):481-6. PubMed ID: 26384137 [TBL] [Abstract][Full Text] [Related]
4. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway. Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells. Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161 [TBL] [Abstract][Full Text] [Related]
6. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009 [TBL] [Abstract][Full Text] [Related]
7. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
8. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration. Luo Z; Yi ZJ; Ou ZL; Han T; Wan T; Tang YC; Wang ZC; Huang FZ J Cell Physiol; 2019 Apr; 234(4):3583-3597. PubMed ID: 30362505 [TBL] [Abstract][Full Text] [Related]
9. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer. Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798 [TBL] [Abstract][Full Text] [Related]
10. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. Xie F; Li C; Zhang X; Peng W; Wen T Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891 [TBL] [Abstract][Full Text] [Related]
11. Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. Ma G; Li G; Fan W; Xu Y; Song S; Guo K; Liu Z Cell Death Dis; 2021 Jun; 12(7):656. PubMed ID: 34183642 [TBL] [Abstract][Full Text] [Related]
12. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b. Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592 [TBL] [Abstract][Full Text] [Related]
13. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645 [TBL] [Abstract][Full Text] [Related]
14. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028 [TBL] [Abstract][Full Text] [Related]
15. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells. Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499 [TBL] [Abstract][Full Text] [Related]
16. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion. He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622 [TBL] [Abstract][Full Text] [Related]
17. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568 [TBL] [Abstract][Full Text] [Related]
19. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450 [TBL] [Abstract][Full Text] [Related]
20. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis. Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]